首页> 外文OA文献 >Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

【2h】

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

机译：支持顺序使用减毒E39肽（E39'）来优化对FBP（E39 + GM-CSF）疫苗的免疫应答的临床试验的初步报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Doreen Jackson; Na Qiao; Julia M Greene; Diane Hale; John Berry; Alfred Trappey; Timothy Vreeland; Guy Clifton; Nuhad Ibrahim; Annie Toms; George E Peoples; Elizabeth A Mittendorf;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine [J] . Doreen Jackson, Na Qiao, Julia M Greene, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：支持顺序使用减毒E39肽（E39'）来优化对FBP（E39 + GM-CSF）疫苗的免疫反应的临床试验的初步报告
2. Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39 ': An analysis of safety and immune response [J] . Vreeland Timothy J., Litton Jennifer K., Qiao Na, Clinical immunology: The official journal of the Clinical Immunology Society . 2018,第期

机译：叶酸结合蛋白（FBP）的相位IB试验（FBP）的肽疫苗，E39和减毒版，E39'：安全性和免疫应答的分析
3. Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39 ' Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding Protein (FBP) Expressing Tumors [J] . Peace Kaitlin, Vreeland Timothy, Myers John W., Journal of the American College of Surgeons . 2017,第4Suppla1期

机译：对随机相1B试验的最终分析评估E39和E39'疫苗测序，优化表达肿瘤的叶酸结合蛋白（FBP）的长期抗肿瘤免疫力
4. Phase I Clinical Trial with Her-2 B-Cell Chimeric and MultiEpitope Based Peptide Vaccines in Patients with Metastatic and/or Recurrent Solid Tumors [C] . Pravin T.P. Kaumaya, Kevin Chu Foy, Joan Garrett American Peptide Symposium . 2009

机译：患者临床试验与患有转移和/或复发性固体瘤的患者的HER-2 B细胞嵌合和多型肽疫苗
5. Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39) to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine [O] . Doreen Jackson, Na Qiao, Julia M Greene, 2015

机译：支持顺序使用减毒E39肽（E39）来优化对FBP（E39 + GM-CSF）疫苗的免疫应答的临床试验的初步报告
6. Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39’: An analysis of safety and immune response [O] . Timothy J. Vreeland, Jennifer K. Litton, Na Qiao, 2018

机译：叶酸结合蛋白（FBP）的相位IB试验（FBP）的肽疫苗，E39和减毒版，E39'：安全性和免疫应答的分析
7. Dengue-2 Vaccine: Virological, Immunological, and Clinical Responses of Six Yellow Fever-Immune Recipients [R] . Bancroft, W. H., Top, F. H., Eckels, K. H., 1980

机译：登革2型疫苗：六种黄热病免疫受体的病毒学，免疫学和临床反应

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

著录项

相似文献

相关主题

期刊订阅